Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2001, p. 4960-4967, Vol. 21, No. 15
Division of Basic Biomedical Sciences,
University of South Dakota School of Medicine, Vermillion, South
Dakota 57069
Received 14 August 2000/Returned for modification 27 September
2000/Accepted 3 May 2001
p27 is a key regulator of cell proliferation through inhibition of
G1 cyclin-dependent kinase (CDK) activity. Translation of
the p27 mRNA is an important control mechanism for determining cellular
levels of the inhibitor. Nearly all eukaryotic mRNAs are translated
through a mechanism involving recognition of the 5' cap by eukaryotic
initiation factor 4E (eIF4E). In quiescent cells eIF4E activity is
repressed, leading to a global decline in translation rates. In
contrast, p27 translation is highest during quiescence, suggesting that
it escapes the general repression of translational initiation. We show
that the 5' untranslated region (5'-UTR) of the p27 mRNA mediates
cap-independent translation. This activity is unaffected by conditions
in which eIF4E is inhibited. In D6P2T cells, elevated cyclic AMP levels
cause a rapid withdrawal from the cell cycle that is correlated with a
striking increase in p27. Under these same conditions, cap-independent
translation from the p27 5'-UTR is enhanced. These results indicate
that regulation of internal initiation of translation is an important
determinant of p27 protein levels.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.4960-4967.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Control of Cyclin-Dependent Kinase Inhibitor p27
Expression by Cap-Independent Translation
*
Corresponding author. Mailing address: University of
South Dakota School of Medicine, Division of Basic Biomedical Sciences, 414 E. Clark St., Vermillion, SD 57069. Phone: (605) 677-5132. Fax:
(605) 677-6381. E-mail: kmiskimi{at}usd.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|